Global Radiopharmaceuticals in Nuclear Medicine Supply, Demand and Key Producers, 2023-2029
Page: 130
Published Date: 03 Aug 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Radiopharmaceuticals in Nuclear Medicine market size is expected to reach $ 6857.2 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases. Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
This report studies the global Radiopharmaceuticals in Nuclear Medicine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceuticals in Nuclear Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceuticals in Nuclear Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiopharmaceuticals in Nuclear Medicine total production and demand, 2018-2029, (K MT)
Global Radiopharmaceuticals in Nuclear Medicine total production value, 2018-2029, (USD Million)
Global Radiopharmaceuticals in Nuclear Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Radiopharmaceuticals in Nuclear Medicine consumption by region & country, CAGR, 2018-2029 & (K MT)
U.S. VS China: Radiopharmaceuticals in Nuclear Medicine domestic production, consumption, key domestic manufacturers and share
Global Radiopharmaceuticals in Nuclear Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K MT)
Global Radiopharmaceuticals in Nuclear Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Radiopharmaceuticals in Nuclear Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K MT).
This reports profiles key players in the global Radiopharmaceuticals in Nuclear Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group and Isotec, Inc. (Sigma-Aldrich), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceuticals in Nuclear Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Radiopharmaceuticals in Nuclear Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Radiopharmaceuticals in Nuclear Medicine Market, Segmentation by Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Global Radiopharmaceuticals in Nuclear Medicine Market, Segmentation by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
Companies Profiled:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Key Questions Answered
1. How big is the global Radiopharmaceuticals in Nuclear Medicine market?
2. What is the demand of the global Radiopharmaceuticals in Nuclear Medicine market?
3. What is the year over year growth of the global Radiopharmaceuticals in Nuclear Medicine market?
4. What is the production and production value of the global Radiopharmaceuticals in Nuclear Medicine market?
5. Who are the key producers in the global Radiopharmaceuticals in Nuclear Medicine market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Radiopharmaceuticals in Nuclear Medicine Introduction
1.2 World Radiopharmaceuticals in Nuclear Medicine Supply & Forecast
1.2.1 World Radiopharmaceuticals in Nuclear Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Radiopharmaceuticals in Nuclear Medicine Production (2018-2029)
1.2.3 World Radiopharmaceuticals in Nuclear Medicine Pricing Trends (2018-2029)
1.3 World Radiopharmaceuticals in Nuclear Medicine Production by Region (Based on Production Site)
1.3.1 World Radiopharmaceuticals in Nuclear Medicine Production Value by Region (2018-2029)
1.3.2 World Radiopharmaceuticals in Nuclear Medicine Production by Region (2018-2029)
1.3.3 World Radiopharmaceuticals in Nuclear Medicine Average Price by Region (2018-2029)
1.3.4 North America Radiopharmaceuticals in Nuclear Medicine Production (2018-2029)
1.3.5 Europe Radiopharmaceuticals in Nuclear Medicine Production (2018-2029)
1.3.6 China Radiopharmaceuticals in Nuclear Medicine Production (2018-2029)
1.3.7 Japan Radiopharmaceuticals in Nuclear Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceuticals in Nuclear Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiopharmaceuticals in Nuclear Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Radiopharmaceuticals in Nuclear Medicine Demand (2018-2029)
2.2 World Radiopharmaceuticals in Nuclear Medicine Consumption by Region
2.2.1 World Radiopharmaceuticals in Nuclear Medicine Consumption by Region (2018-2023)
2.2.2 World Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029)
2.4 China Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029)
2.5 Europe Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029)
2.6 Japan Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029)
2.7 South Korea Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029)
2.8 ASEAN Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029)
2.9 India Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029)
3.1 World Radiopharmaceuticals in Nuclear Medicine Production Value by Manufacturer (2018-2023)
3.2 World Radiopharmaceuticals in Nuclear Medicine Production by Manufacturer (2018-2023)
3.3 World Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturer (2018-2023)
3.4 Radiopharmaceuticals in Nuclear Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Radiopharmaceuticals in Nuclear Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Radiopharmaceuticals in Nuclear Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Radiopharmaceuticals in Nuclear Medicine in 2022
3.6 Radiopharmaceuticals in Nuclear Medicine Market: Overall Company Footprint Analysis
3.6.1 Radiopharmaceuticals in Nuclear Medicine Market: Region Footprint
3.6.2 Radiopharmaceuticals in Nuclear Medicine Market: Company Product Type Footprint
3.6.3 Radiopharmaceuticals in Nuclear Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Value Comparison
4.1.1 United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Comparison
4.2.1 United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Radiopharmaceuticals in Nuclear Medicine Consumption Comparison
4.3.1 United States VS China: Radiopharmaceuticals in Nuclear Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Radiopharmaceuticals in Nuclear Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Radiopharmaceuticals in Nuclear Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Radiopharmaceuticals in Nuclear Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production (2018-2023)
4.5 China Based Radiopharmaceuticals in Nuclear Medicine Manufacturers and Market Share
4.5.1 China Based Radiopharmaceuticals in Nuclear Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production (2018-2023)
4.6 Rest of World Based Radiopharmaceuticals in Nuclear Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Radiopharmaceuticals in Nuclear Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production (2018-2023)
5.1 World Radiopharmaceuticals in Nuclear Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Diagnostic Radiopharmaceuticals
5.2.2 Therapy Radiopharmaceuticals
5.2.3 Enriched Stable Isotopes
5.3 Market Segment by Type
5.3.1 World Radiopharmaceuticals in Nuclear Medicine Production by Type (2018-2029)
5.3.2 World Radiopharmaceuticals in Nuclear Medicine Production Value by Type (2018-2029)
5.3.3 World Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2018-2029)
6.1 World Radiopharmaceuticals in Nuclear Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diagnostic Application
6.2.2 Therapeutic Application
6.2.3 Research
6.2.4 Pharmaceutical
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Radiopharmaceuticals in Nuclear Medicine Production by Application (2018-2029)
6.3.2 World Radiopharmaceuticals in Nuclear Medicine Production Value by Application (2018-2029)
6.3.3 World Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2018-2029)
7.1 Bracco Imaging S.P.A.
7.1.1 Bracco Imaging S.P.A. Details
7.1.2 Bracco Imaging S.P.A. Major Business
7.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bracco Imaging S.P.A. Recent Developments/Updates
7.1.6 Bracco Imaging S.P.A. Competitive Strengths & Weaknesses
7.2 Cambridge Isotope Laboratories, Inc.
7.2.1 Cambridge Isotope Laboratories, Inc. Details
7.2.2 Cambridge Isotope Laboratories, Inc. Major Business
7.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Cambridge Isotope Laboratories, Inc. Recent Developments/Updates
7.2.6 Cambridge Isotope Laboratories, Inc. Competitive Strengths & Weaknesses
7.3 Cardinal Health, Inc.
7.3.1 Cardinal Health, Inc. Details
7.3.2 Cardinal Health, Inc. Major Business
7.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cardinal Health, Inc. Recent Developments/Updates
7.3.6 Cardinal Health, Inc. Competitive Strengths & Weaknesses
7.4 Covidien, Plc
7.4.1 Covidien, Plc Details
7.4.2 Covidien, Plc Major Business
7.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product and Services
7.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Covidien, Plc Recent Developments/Updates
7.4.6 Covidien, Plc Competitive Strengths & Weaknesses
7.5 Eczacibasi-Monrol
7.5.1 Eczacibasi-Monrol Details
7.5.2 Eczacibasi-Monrol Major Business
7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product and Services
7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eczacibasi-Monrol Recent Developments/Updates
7.5.6 Eczacibasi-Monrol Competitive Strengths & Weaknesses
7.6 Fujifilm Holdings Corporation
7.6.1 Fujifilm Holdings Corporation Details
7.6.2 Fujifilm Holdings Corporation Major Business
7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Fujifilm Holdings Corporation Recent Developments/Updates
7.6.6 Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
7.7 GE Healthcare (Subsidiary Of General Electric Company)
7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Details
7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Major Business
7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product and Services
7.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
7.7.6 GE Healthcare (Subsidiary Of General Electric Company) Competitive Strengths & Weaknesses
7.8 IBA Group
7.8.1 IBA Group Details
7.8.2 IBA Group Major Business
7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Product and Services
7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 IBA Group Recent Developments/Updates
7.8.6 IBA Group Competitive Strengths & Weaknesses
7.9 Isotec, Inc. (Sigma-Aldrich)
7.9.1 Isotec, Inc. (Sigma-Aldrich) Details
7.9.2 Isotec, Inc. (Sigma-Aldrich) Major Business
7.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product and Services
7.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Developments/Updates
7.9.6 Isotec, Inc. (Sigma-Aldrich) Competitive Strengths & Weaknesses
7.10 Lantheus Medical Imaging, Inc.
7.10.1 Lantheus Medical Imaging, Inc. Details
7.10.2 Lantheus Medical Imaging, Inc. Major Business
7.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Lantheus Medical Imaging, Inc. Recent Developments/Updates
7.10.6 Lantheus Medical Imaging, Inc. Competitive Strengths & Weaknesses
7.11 Nordion, Inc.
7.11.1 Nordion, Inc. Details
7.11.2 Nordion, Inc. Major Business
7.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Nordion, Inc. Recent Developments/Updates
7.11.6 Nordion, Inc. Competitive Strengths & Weaknesses
7.12 Ntp Radioisotopes (Pty), Ltd.
7.12.1 Ntp Radioisotopes (Pty), Ltd. Details
7.12.2 Ntp Radioisotopes (Pty), Ltd. Major Business
7.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Developments/Updates
7.12.6 Ntp Radioisotopes (Pty), Ltd. Competitive Strengths & Weaknesses
7.13 Siemens Healthcare (Subsidiary Of Siemens AG)
7.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Details
7.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Major Business
7.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product and Services
7.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments/Updates
7.13.6 Siemens Healthcare (Subsidiary Of Siemens AG) Competitive Strengths & Weaknesses
7.14 Taiyo Nippon Sanso Corporation
7.14.1 Taiyo Nippon Sanso Corporation Details
7.14.2 Taiyo Nippon Sanso Corporation Major Business
7.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
7.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Taiyo Nippon Sanso Corporation Recent Developments/Updates
7.14.6 Taiyo Nippon Sanso Corporation Competitive Strengths & Weaknesses
7.15 Urenco Limited
7.15.1 Urenco Limited Details
7.15.2 Urenco Limited Major Business
7.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product and Services
7.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Urenco Limited Recent Developments/Updates
7.15.6 Urenco Limited Competitive Strengths & Weaknesses
7.16 Rotem Industries, Ltd., Inc.
7.16.1 Rotem Industries, Ltd., Inc. Details
7.16.2 Rotem Industries, Ltd., Inc. Major Business
7.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Rotem Industries, Ltd., Inc. Recent Developments/Updates
7.16.6 Rotem Industries, Ltd., Inc. Competitive Strengths & Weaknesses
7.17 Australian Nuclear Association And Technology Organization (ANSTO)
7.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Details
7.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Major Business
7.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product and Services
7.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments/Updates
7.17.6 Australian Nuclear Association And Technology Organization (ANSTO) Competitive Strengths & Weaknesses
7.18 Board of Radiation And Isotope Technology (BRIT)
7.18.1 Board of Radiation And Isotope Technology (BRIT) Details
7.18.2 Board of Radiation And Isotope Technology (BRIT) Major Business
7.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product and Services
7.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Developments/Updates
7.18.6 Board of Radiation And Isotope Technology (BRIT) Competitive Strengths & Weaknesses
7.19 Institute of Atomic Energy Polatom Radioisotope Centre
7.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Details
7.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Major Business
7.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product and Services
7.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments/Updates
7.19.6 Institute of Atomic Energy Polatom Radioisotope Centre Competitive Strengths & Weaknesses
7.20 Institute of Isotopes Co., Ltd.
7.20.1 Institute of Isotopes Co., Ltd. Details
7.20.2 Institute of Isotopes Co., Ltd. Major Business
7.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
7.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Institute of Isotopes Co., Ltd. Recent Developments/Updates
7.20.6 Institute of Isotopes Co., Ltd. Competitive Strengths & Weaknesses
7.21 Institute Of Radioelement (IRE)
7.21.1 Institute Of Radioelement (IRE) Details
7.21.2 Institute Of Radioelement (IRE) Major Business
7.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product and Services
7.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Institute Of Radioelement (IRE) Recent Developments/Updates
7.21.6 Institute Of Radioelement (IRE) Competitive Strengths & Weaknesses
8.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain
8.2 Radiopharmaceuticals in Nuclear Medicine Upstream Analysis
8.2.1 Radiopharmaceuticals in Nuclear Medicine Core Raw Materials
8.2.2 Main Manufacturers of Radiopharmaceuticals in Nuclear Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Radiopharmaceuticals in Nuclear Medicine Production Mode
8.6 Radiopharmaceuticals in Nuclear Medicine Procurement Model
8.7 Radiopharmaceuticals in Nuclear Medicine Industry Sales Model and Sales Channels
8.7.1 Radiopharmaceuticals in Nuclear Medicine Sales Model
8.7.2 Radiopharmaceuticals in Nuclear Medicine Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Radiopharmaceuticals in Nuclear Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Radiopharmaceuticals in Nuclear Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Radiopharmaceuticals in Nuclear Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Radiopharmaceuticals in Nuclear Medicine Production by Region (2018-2023) & (K MT)
Table 7. World Radiopharmaceuticals in Nuclear Medicine Production by Region (2024-2029) & (K MT)
Table 8. World Radiopharmaceuticals in Nuclear Medicine Production Market Share by Region (2018-2023)
Table 9. World Radiopharmaceuticals in Nuclear Medicine Production Market Share by Region (2024-2029)
Table 10. World Radiopharmaceuticals in Nuclear Medicine Average Price by Region (2018-2023) & (USD/MT)
Table 11. World Radiopharmaceuticals in Nuclear Medicine Average Price by Region (2024-2029) & (USD/MT)
Table 12. Radiopharmaceuticals in Nuclear Medicine Major Market Trends
Table 13. World Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K MT)
Table 14. World Radiopharmaceuticals in Nuclear Medicine Consumption by Region (2018-2023) & (K MT)
Table 15. World Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Region (2024-2029) & (K MT)
Table 16. World Radiopharmaceuticals in Nuclear Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Radiopharmaceuticals in Nuclear Medicine Producers in 2022
Table 18. World Radiopharmaceuticals in Nuclear Medicine Production by Manufacturer (2018-2023) & (K MT)
Table 19. Production Market Share of Key Radiopharmaceuticals in Nuclear Medicine Producers in 2022
Table 20. World Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 21. Global Radiopharmaceuticals in Nuclear Medicine Company Evaluation Quadrant
Table 22. World Radiopharmaceuticals in Nuclear Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Radiopharmaceuticals in Nuclear Medicine Production Site of Key Manufacturer
Table 24. Radiopharmaceuticals in Nuclear Medicine Market: Company Product Type Footprint
Table 25. Radiopharmaceuticals in Nuclear Medicine Market: Company Product Application Footprint
Table 26. Radiopharmaceuticals in Nuclear Medicine Competitive Factors
Table 27. Radiopharmaceuticals in Nuclear Medicine New Entrant and Capacity Expansion Plans
Table 28. Radiopharmaceuticals in Nuclear Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Radiopharmaceuticals in Nuclear Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Radiopharmaceuticals in Nuclear Medicine Production Comparison, (2018 & 2022 & 2029) & (K MT)
Table 31. United States VS China Radiopharmaceuticals in Nuclear Medicine Consumption Comparison, (2018 & 2022 & 2029) & (K MT)
Table 32. United States Based Radiopharmaceuticals in Nuclear Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production (2018-2023) & (K MT)
Table 36. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Market Share (2018-2023)
Table 37. China Based Radiopharmaceuticals in Nuclear Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production (2018-2023) & (K MT)
Table 41. China Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Radiopharmaceuticals in Nuclear Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production (2018-2023) & (K MT)
Table 46. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Market Share (2018-2023)
Table 47. World Radiopharmaceuticals in Nuclear Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Radiopharmaceuticals in Nuclear Medicine Production by Type (2018-2023) & (K MT)
Table 49. World Radiopharmaceuticals in Nuclear Medicine Production by Type (2024-2029) & (K MT)
Table 50. World Radiopharmaceuticals in Nuclear Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Radiopharmaceuticals in Nuclear Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2018-2023) & (USD/MT)
Table 53. World Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2024-2029) & (USD/MT)
Table 54. World Radiopharmaceuticals in Nuclear Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Radiopharmaceuticals in Nuclear Medicine Production by Application (2018-2023) & (K MT)
Table 56. World Radiopharmaceuticals in Nuclear Medicine Production by Application (2024-2029) & (K MT)
Table 57. World Radiopharmaceuticals in Nuclear Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Radiopharmaceuticals in Nuclear Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2018-2023) & (USD/MT)
Table 60. World Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2024-2029) & (USD/MT)
Table 61. Bracco Imaging S.P.A. Basic Information, Manufacturing Base and Competitors
Table 62. Bracco Imaging S.P.A. Major Business
Table 63. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 64. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bracco Imaging S.P.A. Recent Developments/Updates
Table 66. Bracco Imaging S.P.A. Competitive Strengths & Weaknesses
Table 67. Cambridge Isotope Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Cambridge Isotope Laboratories, Inc. Major Business
Table 69. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 70. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Cambridge Isotope Laboratories, Inc. Recent Developments/Updates
Table 72. Cambridge Isotope Laboratories, Inc. Competitive Strengths & Weaknesses
Table 73. Cardinal Health, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Cardinal Health, Inc. Major Business
Table 75. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 76. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cardinal Health, Inc. Recent Developments/Updates
Table 78. Cardinal Health, Inc. Competitive Strengths & Weaknesses
Table 79. Covidien, Plc Basic Information, Manufacturing Base and Competitors
Table 80. Covidien, Plc Major Business
Table 81. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 82. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Covidien, Plc Recent Developments/Updates
Table 84. Covidien, Plc Competitive Strengths & Weaknesses
Table 85. Eczacibasi-Monrol Basic Information, Manufacturing Base and Competitors
Table 86. Eczacibasi-Monrol Major Business
Table 87. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 88. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eczacibasi-Monrol Recent Developments/Updates
Table 90. Eczacibasi-Monrol Competitive Strengths & Weaknesses
Table 91. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 92. Fujifilm Holdings Corporation Major Business
Table 93. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 94. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Fujifilm Holdings Corporation Recent Developments/Updates
Table 96. Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
Table 97. GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base and Competitors
Table 98. GE Healthcare (Subsidiary Of General Electric Company) Major Business
Table 99. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 100. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
Table 102. GE Healthcare (Subsidiary Of General Electric Company) Competitive Strengths & Weaknesses
Table 103. IBA Group Basic Information, Manufacturing Base and Competitors
Table 104. IBA Group Major Business
Table 105. IBA Group Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 106. IBA Group Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. IBA Group Recent Developments/Updates
Table 108. IBA Group Competitive Strengths & Weaknesses
Table 109. Isotec, Inc. (Sigma-Aldrich) Basic Information, Manufacturing Base and Competitors
Table 110. Isotec, Inc. (Sigma-Aldrich) Major Business
Table 111. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 112. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Isotec, Inc. (Sigma-Aldrich) Recent Developments/Updates
Table 114. Isotec, Inc. (Sigma-Aldrich) Competitive Strengths & Weaknesses
Table 115. Lantheus Medical Imaging, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Lantheus Medical Imaging, Inc. Major Business
Table 117. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 118. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Lantheus Medical Imaging, Inc. Recent Developments/Updates
Table 120. Lantheus Medical Imaging, Inc. Competitive Strengths & Weaknesses
Table 121. Nordion, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Nordion, Inc. Major Business
Table 123. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 124. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Nordion, Inc. Recent Developments/Updates
Table 126. Nordion, Inc. Competitive Strengths & Weaknesses
Table 127. Ntp Radioisotopes (Pty), Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Ntp Radioisotopes (Pty), Ltd. Major Business
Table 129. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 130. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Ntp Radioisotopes (Pty), Ltd. Recent Developments/Updates
Table 132. Ntp Radioisotopes (Pty), Ltd. Competitive Strengths & Weaknesses
Table 133. Siemens Healthcare (Subsidiary Of Siemens AG) Basic Information, Manufacturing Base and Competitors
Table 134. Siemens Healthcare (Subsidiary Of Siemens AG) Major Business
Table 135. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 136. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments/Updates
Table 138. Siemens Healthcare (Subsidiary Of Siemens AG) Competitive Strengths & Weaknesses
Table 139. Taiyo Nippon Sanso Corporation Basic Information, Manufacturing Base and Competitors
Table 140. Taiyo Nippon Sanso Corporation Major Business
Table 141. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 142. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Taiyo Nippon Sanso Corporation Recent Developments/Updates
Table 144. Taiyo Nippon Sanso Corporation Competitive Strengths & Weaknesses
Table 145. Urenco Limited Basic Information, Manufacturing Base and Competitors
Table 146. Urenco Limited Major Business
Table 147. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 148. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Urenco Limited Recent Developments/Updates
Table 150. Urenco Limited Competitive Strengths & Weaknesses
Table 151. Rotem Industries, Ltd., Inc. Basic Information, Manufacturing Base and Competitors
Table 152. Rotem Industries, Ltd., Inc. Major Business
Table 153. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 154. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Rotem Industries, Ltd., Inc. Recent Developments/Updates
Table 156. Rotem Industries, Ltd., Inc. Competitive Strengths & Weaknesses
Table 157. Australian Nuclear Association And Technology Organization (ANSTO) Basic Information, Manufacturing Base and Competitors
Table 158. Australian Nuclear Association And Technology Organization (ANSTO) Major Business
Table 159. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 160. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments/Updates
Table 162. Australian Nuclear Association And Technology Organization (ANSTO) Competitive Strengths & Weaknesses
Table 163. Board of Radiation And Isotope Technology (BRIT) Basic Information, Manufacturing Base and Competitors
Table 164. Board of Radiation And Isotope Technology (BRIT) Major Business
Table 165. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 166. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Board of Radiation And Isotope Technology (BRIT) Recent Developments/Updates
Table 168. Board of Radiation And Isotope Technology (BRIT) Competitive Strengths & Weaknesses
Table 169. Institute of Atomic Energy Polatom Radioisotope Centre Basic Information, Manufacturing Base and Competitors
Table 170. Institute of Atomic Energy Polatom Radioisotope Centre Major Business
Table 171. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 172. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments/Updates
Table 174. Institute of Atomic Energy Polatom Radioisotope Centre Competitive Strengths & Weaknesses
Table 175. Institute of Isotopes Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 176. Institute of Isotopes Co., Ltd. Major Business
Table 177. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 178. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Institute of Isotopes Co., Ltd. Recent Developments/Updates
Table 180. Institute Of Radioelement (IRE) Basic Information, Manufacturing Base and Competitors
Table 181. Institute Of Radioelement (IRE) Major Business
Table 182. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product and Services
Table 183. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Global Key Players of Radiopharmaceuticals in Nuclear Medicine Upstream (Raw Materials)
Table 185. Radiopharmaceuticals in Nuclear Medicine Typical Customers
Table 186. Radiopharmaceuticals in Nuclear Medicine Typical Distributors
List of Figure
Figure 1. Radiopharmaceuticals in Nuclear Medicine Picture
Figure 2. World Radiopharmaceuticals in Nuclear Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Radiopharmaceuticals in Nuclear Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Radiopharmaceuticals in Nuclear Medicine Production (2018-2029) & (K MT)
Figure 5. World Radiopharmaceuticals in Nuclear Medicine Average Price (2018-2029) & (USD/MT)
Figure 6. World Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Radiopharmaceuticals in Nuclear Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Radiopharmaceuticals in Nuclear Medicine Production (2018-2029) & (K MT)
Figure 9. Europe Radiopharmaceuticals in Nuclear Medicine Production (2018-2029) & (K MT)
Figure 10. China Radiopharmaceuticals in Nuclear Medicine Production (2018-2029) & (K MT)
Figure 11. Japan Radiopharmaceuticals in Nuclear Medicine Production (2018-2029) & (K MT)
Figure 12. Radiopharmaceuticals in Nuclear Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 15. World Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 17. China Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 18. Europe Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 19. Japan Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 20. South Korea Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 21. ASEAN Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 22. India Radiopharmaceuticals in Nuclear Medicine Consumption (2018-2029) & (K MT)
Figure 23. Producer Shipments of Radiopharmaceuticals in Nuclear Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceuticals in Nuclear Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceuticals in Nuclear Medicine Markets in 2022
Figure 26. United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Radiopharmaceuticals in Nuclear Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Radiopharmaceuticals in Nuclear Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Market Share 2022
Figure 32. World Radiopharmaceuticals in Nuclear Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Type in 2022
Figure 34. Diagnostic Radiopharmaceuticals
Figure 35. Therapy Radiopharmaceuticals
Figure 36. Enriched Stable Isotopes
Figure 37. World Radiopharmaceuticals in Nuclear Medicine Production Market Share by Type (2018-2029)
Figure 38. World Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Type (2018-2029)
Figure 39. World Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2018-2029) & (USD/MT)
Figure 40. World Radiopharmaceuticals in Nuclear Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Application in 2022
Figure 42. Diagnostic Application
Figure 43. Therapeutic Application
Figure 44. Research
Figure 45. Pharmaceutical
Figure 46. Other
Figure 47. World Radiopharmaceuticals in Nuclear Medicine Production Market Share by Application (2018-2029)
Figure 48. World Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Application (2018-2029)
Figure 49. World Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2018-2029) & (USD/MT)
Figure 50. Radiopharmaceuticals in Nuclear Medicine Industry Chain
Figure 51. Radiopharmaceuticals in Nuclear Medicine Procurement Model
Figure 52. Radiopharmaceuticals in Nuclear Medicine Sales Model
Figure 53. Radiopharmaceuticals in Nuclear Medicine Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Bracco Imaging S.P.A. Cambridge Isotope Laboratories, Inc. Cardinal Health, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (Subsidiary Of General Electric Company) IBA Group Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. Nordion, Inc. Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (Subsidiary Of Siemens AG) Taiyo Nippon Sanso Corporation Urenco Limited Rotem Industries, Ltd., Inc. Australian Nuclear Association And Technology Organization (ANSTO) Board of Radiation And Isotope Technology (BRIT) Institute of Atomic Energy Polatom Radioisotope Centre Institute of Isotopes Co., Ltd. Institute Of Radioelement (IRE)
Related Reports
03 Aug 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
